SynCore Biotechnology Co

SynCore Biotechnology Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of SynCore Biotechnology Co (4192.TWO) as of Nov 17, 2026 is -14.85. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -12.14 — a change of 22.37% (lower).

EV/EBITDA

-14.85

YoY

22.37%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of SynCore Biotechnology Co is 2025 -14.85 . EV/EBITDA (Enterprise Value to EBITDA) of SynCore Biotechnology Co was 2024 -12.14 . It decreases by 22.37% lower compared to the previous year.

The SynCore Biotechnology Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-2.45 TWD
Jan 1, 2019
-1.86 TWD
Jan 1, 2020
-0.97 TWD
Jan 1, 2021
-0.58 TWD
Jan 1, 2022
-2.65 TWD
Jan 1, 2023
-11.55 TWD
Jan 1, 2024
-12.14 TWD
Jan 1, 2025
-14.85 TWD
The SynCore Biotechnology Co EV/EBITDA history
YEAREV/EBITDAYoY
-14.85+22.37%
-12.14+5.10%
-11.55+336.45%
-2.65+353.72%
-0.58-39.74%
-0.97-47.98%
-1.86-23.95%
-2.45-13.69%
-2.83-6.10%
-3.02-11.40%
-3.41-4,266.63%
0.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

EV/EBITDA (Enterprise Value to EBITDA) of SynCore Biotechnology Co is -14.85 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of SynCore Biotechnology Co changed from -12.14 to -14.85, representing a 22.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s SynCore Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SynCore Biotechnology Co

All Key Metrics — SynCore Biotechnology Co